https://www.selleckchem.com/pr....oducts/derazantinib.
After the programme, statistically significant improvement was found in ODI (47.5 to 45.0, p= 0.01) and SFSS (98.0 to 109.5, p 0.001). There was statistically significant improvement (p 0.01) in sitting, standing, walking tolerance and straight leg raise tests. 47.4% of the patients were able to meet their work demand. Multivariate logistic regression model (R = 59.5%, χ (9) = 85.640, p 0.001) demonstrated that lower initial job demand level and higher patient-perceived back function correlated with greater likelihood o
Gefällt mir
Kommentar
Teilen
